Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2019, Article ID 9347198, 5 pages
https://doi.org/10.1155/2019/9347198
Case Report

Acute Coronary Syndrome (ACS) due to Coronary Artery Embolism in a Patient with Atrial Fibrillation

1Department of Internal Medicine, Advocate Illinois Masonic Medical Center, 836 W Wellington Ave., Chicago, IL 60657, USA
2Department of Cardiology, Advocate Illinois Masonic Medical Center, 836 W Wellington Ave., Chicago, IL 60657, USA

Correspondence should be addressed to Hussein Daoud; moc.htlaehetacovda@duoad.niessuh

Received 3 April 2019; Revised 9 August 2019; Accepted 5 September 2019; Published 10 October 2019

Academic Editor: Aiden Abidov

Copyright © 2019 Hussein Daoud et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Acute coronary syndrome (ACS) secondary to a coronary embolism is an unusual occurrence, yet an important consideration given the difficult diagnosis. We report a case of a 69-year-old male with a medical history of paroxysmal atrial fibrillation who presented with chest pain and shortness of breath. A coronary angiogram was significant for three focal transluminal and translucent areas in the ostial, mid, and distal circumflex artery consistent with embolic disease. The patient was subsequently managed medically with anticoagulation. Despite being a relatively rare entity, thromboembolism into the coronary arteries can provoke an acute myocardial infarction, with atrial fibrillation being the most common risk factor. Treatment modalities for ACS secondary to thromboembolism include stent placement, intracoronary thrombolysis, and thrombus aspiration.

1. Introduction

Acute myocardial infarction secondary to a coronary embolism was first reported in 1856 by the famous German physician Rudolf Virchow [1]. Approximately 3% of acute coronary syndromes (ACS) are caused by a coronary embolism. Coronary emboli can arise through various mechanisms including a left atrial appendage thrombus due to atrial fibrillation, valve vegetations secondary to infective or autoimmune endocarditis, deep venous thrombi embolizing paradoxically through a patent foramen ovale (PFO), or iatrogenic secondary to coronary interventions [2]. Of these, atrial fibrillation is thought to be the most common etiology of coronary emboli, though there are few cases reported in the literature. Particularly, a non-ST-segment elevation myocardial infarction (NSTEMI) caused by embolic occlusion of a coronary artery in the setting of atrial fibrillation is a rare entity. The clinical presentation is like ACS of any cause. In this report, we discuss a case of a 69-year-old male with a history of paroxysmal atrial fibrillation who presented with chest pain and exertional dyspnea. The coronary angiogram demonstrated three lesions in the ostial, mid, and distal circumflex artery consistent with emboli.

2. Case Report

A 69-year-old male presented to the emergency department complaining of chest pain and shortness of breath. His medical history was significant for paroxysmal atrial fibrillation on warfarin, coronary artery disease (CAD) with a proximal left anterior descending artery (LAD) stent, balloon valvuloplasty for severe aortic stenosis, and end-stage renal disease (ESRD) treated with peritoneal dialysis. The patient reported intermittent chest tightness that worsened with exertion and that was associated with progressive shortness of breath for one week before hospital arrival.

On admission, his heart rate was 104 beats per minute, blood pressure was 104/67 mmHg, respiratory rate was 22 breaths per minute, and the patient’s oxygen saturation was above 94% on ambient air. The physical exam revealed a grade II/VI systolic ejection murmur over the aortic valve area. Labs showed a potassium of 5.8, BUN of 65 mg/dL, creatinine of 12.47 mg/dL (unknown baseline), hemoglobin of 8.4 g/dL, and a troponin I of 2.76 ng/dL () that peaked on repeat at 3.79 ng/dL. His international normalized ratio (INR) on admission was 2.0, though his compliance with anticoagulation and the INR in the weeks leading up to his admission was unknown. A chest X-ray was remarkable for mild cardiomegaly, interstitial pulmonary edema, and trace bilateral pleural effusions. An electrocardiogram (ECG) showed a normal sinus rhythm with an old apical infarct, and a transthoracic echocardiogram (TTE) revealed an ejection fraction of 15-20% with grade two diastolic dysfunction and “possible” severe aortic valve stenosis (Figure 1).

Figure 1: Admission electrocardiogram (ECG) on the left with a normal sinus rhythm and ECG on the right taken during the hospital stay showing atrial fibrillation with a rapid ventricular response.

The patient was diagnosed with a non-ST-segment elevation myocardial infarction (NSTEMI) and underwent both a right- and left-sided heart catheterization. The coronary angiogram revealed three focal transluminal and translucent areas in the ostial, mid, and distal circumflex artery consistent with coronary emboli (Figure 2). The left circumflex artery was otherwise angiographically normal. Given the patient’s low ejection fraction and history of severe aortic stenosis, the interventional cardiologist recommended medical management with anticoagulation, instead of potential thrombolysis or thrombus aspiration, as he would be high risk for any coronary intervention.

Figure 2: Left heart catheterization showing three focal transluminal and translucent areas in the ostial, mid, and distal circumflex artery that was mobile and hazy appearing—concerning for emboli.

A transesophageal echocardiogram (TEE) with agitated saline was subsequently ordered and did not reveal a patent foramen ovale (PFO), atrial septal defect (ASD), evidence of an embolic source (in the left atrial appendage or left ventricle), or any valve vegetation. The patient denied any episodes of chest pain or dyspnea during his hospital stay. He was deemed a poor candidate for aortic valve surgery by cardiothoracic surgery and was ultimately discharged on his home doses of aspirin, carvedilol, amiodarone, and warfarin with a follow-up for continued evaluation for a transcatheter aortic valve replacement (TAVR) procedure as his prior balloon valvuloplasty was completed as a bridging intervention.

3. Discussion

Individuals with atrial fibrillation are at an increased risk of thrombus formation in the left atrium, particularly in the left atrial appendage, through Virchow’s triad of blood stasis, endothelial damage, and hypercoagulable state. They may also develop nonleft atrial appendage thrombi due to the overall diseased state of the atrium (atriopathy). This subsequently puts this population at an increased risk of thromboembolic events of the systemic circulation. Thromboembolism most often occurs during episodes of fibrillation or within the first ten days following cardioversion back to sinus rhythm. Sites of systemic embolism include the brain, splenic artery, renal artery, mesenteric artery, and limbs [3].

Myocardial infarction has been known to cause atrial fibrillation through multiple mechanisms, including ventricular ischemia/infarction and subsequent atrial stretching or directly through atrial ischemia [4]. Conversely, atrial fibrillation has been linked to myocardial infarction through its association with multiple atherosclerotic risk factors including diabetes, hypertension, and dyslipidemia. Additionally, atrial fibrillation is associated with inflammation that may promote a prothrombotic state and subsequent myocardial infarction. When these two conditions coincide, clinical management becomes more complex given the higher risk of bleeding when combining anticoagulant and antiplatelet medications [5].

The phenomenon of thromboembolism into the coronary arteries is rare with an unknown prevalence given its difficult diagnosis. Acute myocardial infarction secondary to a coronary embolism was first reported in 1856 by the famous German physician Rudolf Virchow [1]. In patients with myocardial infarction, 4-7% are found to not have atherosclerotic vascular disease [6]. In an autopsy study of 419 patients, 55 (13%) were found to have an embolic infarct in their coronary arteries [7]. A study by Shibata et al. looked at new-onset acute myocardial infarctions between 2001 and 2013, and 1776 consecutive cases were analyzed with a focus on coronary embolism (CE) diagnosis through angiography, histology, and imaging. In that study, 52 patients were acknowledged to have CE (2.9%) and the most common etiologies were atrial fibrillation, cardiomyopathy, and valvular heart disease with a prevalence of 73%, 25%, and 15%, respectively [8].

Therefore, even though atrial fibrillation is thought to be the most common risk factor, other potential sources for coronary embolization exist. These include a left ventricular mural thrombus from a prior myocardial infarction, thromboemboli from the trabeculated myocardium in noncompaction cardiomyopathy, or intrapulmonary shunting through arteriovenous malformations or fistulae [9, 10]. However, cardiac magnetic resonance imaging (MRI), computed tomography angiography (CTA) chest, or ventilation-perfusion (VQ) studies, which could identify some of these other potential causes, were not pursued in this patient.

Coronary embolisms can manifest as a non-ST-segment elevation myocardial infarction (NSTEMI) like in our patient or an ST-segment elevation myocardial infarction (STEMI) as seen in other case reports (Table 1). The condition has also been seen in the setting of a concomitant stroke and diffuse systemic embolization [11]. The National Cerebral and Cardiovascular Center (NCVC) criteria for the clinical diagnosis of coronary artery embolism (CE) was proposed by Shibata et al. and uses combinations of major and minor criteria to categorize the diagnosis of CE into definite or probable [8] (Table 2). In that study, out of the 52 patients, 32 met the definitive criteria and 20 the probable criteria. Based on the proposed criteria, our patient would fall under the category of “probable” CE given the angiographic findings and risk factor of atrial fibrillation (one major and one minor criterion). Although no embolic source was found on echocardiography, the absence does not rule out CE.

Table 1: Reported cases of coronary artery embolism with embolus location and outcomes.
Table 2: Proposed National Cerebral and Cardiovascular Center (NCVC) criteria for the clinical diagnosis of coronary artery embolism (CE) [1].

In our case report, the patient was managed medically with anticoagulation given his high risk for coronary intervention, but additional therapeutic options exist that are consistent with other causes of ACS including stent placement, intracoronary thrombolysis, and thrombus aspiration—which is generally favored because of the decreased risk of distal embolization [1].

4. Conclusion

Coronary embolism is an unusual and therefore likely an underreported etiology of ACS. Patients often have varying levels of concurrent atherosclerosis which can further confound the picture. Distinctions can, however, be made angiographically. Management is the same for both: anticoagulation, thrombolysis, and percutaneous coronary intervention (PCI). Thrombus aspiration may be considered in patients with a heavy thrombus burden. However, following initial management, it is vital to further investigate the source of emboli in these patients. It is important to contemplate atrial fibrillation not only as a consequence of ACS but also as a cause of it. Additionally, it is important to consider bleeding risks given the need for both anticoagulation and antiplatelet therapy in these groups of patients.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Supplementary Materials

Left heart catheterization showing three focal transluminal, translucent areas in the ostial, mid, and distal circumflex artery that was mobile and hazy appearing—concerning for emboli. (Supplementary Materials)

References

  1. S. Van de Walle and K. Dujardin, “A case of coronary embolism in a patient with paroxysmal atrial fibrillation receiving tamoxifen,” International Journal of Cardiology, vol. 123, no. 1, pp. 66–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. C. E. Raphael, J. A. Heit, G. S. Reeder et al., “Coronary embolus,” JACC: Cardiovascular Interventions, vol. 11, no. 2, pp. 172–180, 2018. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Menke, L. Lüthje, A. Kastrup, and J. Larsen, “Thromboembolism in atrial fibrillation,” The American Journal of Cardiology, vol. 105, no. 4, pp. 502–510, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Alasady, N. J. Shipp, A. G. Brooks et al., “Myocardial infarction and atrial fibrillation: importance of atrial ischemia,” Circulation: Arrhythmia and Electrophysiology, vol. 6, no. 4, pp. 738–745, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Violi, E. Z. Soliman, P. Pignatelli, and D. Pastori, “Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms,” Journal of the American Heart Association, vol. 5, no. 5, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Waller, B. F. Waller, E. T. A. Fry, J. B. Hermiller, T. Peters, and J. D. Slack, “Nonatherosclerotic causes of coronary artery narrowing—part II,” Clinical Cardiology, vol. 19, no. 7, pp. 587–591, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. K. R. Prizel, “Coronary artery embolism and myocardial infarction: a clinicopathologic study of 55 patients,” Annals of Internal Medicine, vol. 88, no. 2, pp. 155–161, 1978. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Shibata, S. Kawakami, T. Noguchi et al., “Prevalence, clinical features, and prognosis of acute myocardial infarction attributable to coronary artery embolism,” Circulation, vol. 132, no. 4, pp. 241–250, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. M. E. Everett, J. N. Kirkpatrick, and R. M. Lang, “Noncompaction of the myocardium complicated by coronary artery embolism,” Journal of the American Society of Echocardiography, vol. 18, no. 2, pp. 194–196, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Windecker, S. Stortecky, and B. Meier, “Paradoxical embolism,” Journal of the American College of Cardiology, vol. 64, no. 4, pp. 403–415, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Nakano, H. Yamagami, and H. Ofuchi, “A case report of systemic embolic events associated with atrial fibrillation,” Acute Medicine & Surgery, vol. 4, no. 1, pp. 127–130, 2017. View at Publisher · View at Google Scholar
  12. S. Antoine, D. Lowe, K. Jessamy, O. Anozie, and V. Frechette, “Myocardial infarction caused by coronary artery thromboembolism in a atrial fibrillation patient on rivaroxaban,” Chest, vol. 150, no. 4, article 100A, 2016. View at Publisher · View at Google Scholar
  13. C. Camaro and W. R. M. Aengevaeren, “Acute myocardial infarction due to coronary artery embolism in a patient with atrial fibrillation,” Netherlands Heart Journal, vol. 17, no. 8, pp. 297–299, 2009. View at Publisher · View at Google Scholar
  14. J. C. Díaz, D. Weir, W. Uribe et al., “Acute myocardial infarction due to coronary embolism in atrial fibrillation: case presentation and systematic review,” Revista Mexicana de Cardiolog, vol. 27, no. 4, pp. 171–180, 2016. View at Google Scholar
  15. R. K. Garg and N. Jolly, “Acute myocardial infarction secondary to thromboembolism in a patient with atrial fibrillation,” International Journal of Cardiology, vol. 123, no. 1, pp. e18–e20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Kotooka, Y. Otsuka, S. Yasuda, I. Morii, A. Kawamura, and S. Miyazaki, “Three cases of acute myocardial infarction due to coronary embolism: treatment using a thrombus aspiration device,” Japanese Heart Journal, vol. 45, no. 5, pp. 861–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Koutsampasopoulos, A. Datsios, S. Grigoriadis, and I. Vogiatzis, “Atrial fibrillation causing ST elevation myocardial infarction due to coronary embolism: case report and review of the literature,” Hippokratia, vol. 20, no. 2, pp. 160–162, 2016. View at Google Scholar
  18. C. J. OSullivan, M. Sprenger, D. Tueller, and F. R. Eberli, “Case report: coronary thromboembolic acute myocardial infarction due to paroxysmal atrial fibrillation occurring after non-cardiac surgery,” BMJ Case Reports, vol. 2015, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Sakai, K. Inoue, and M. Nobuyoshi, “Aspiration thrombectomy of a massive thrombotic embolus in acute myocardial infarction caused by coronary embolism,” International Heart Journal, vol. 48, no. 3, pp. 387–392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Takenaka, M. Horimoto, K. Igarashi, H. Yoshie, I. Tsujino, and M. Morihira, “Multiple coronary thromboemboli complicating valvular heart disease and atrial fibrillation,” American Heart Journal, vol. 131, no. 1, pp. 194–196, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Zakaria, B. A. Share, G. Kaspar, and D. Small, “A fluttering coronary event,” Journal of Family Medicine and Primary Care, vol. 7, no. 2, pp. 468–470, 2018. View at Publisher · View at Google Scholar